FGFR2 and breast carcinoma: Results of genotype analysis on the four selected FGFR2 intronic variants (rs2981582C/T, rs1219648A/G, rs2981578A/G, and rs7895676T/C) were available from 368 breast cancer cases/484 healthy controls and a notably significant association with breast cancer susceptibility was observed.